Posts by Tracey G. Simon, MD
-
Daily Aspirin Use Tied to Lower Risk of Fibrosis Progression in Nonalcholic Fatty Liver Disease
Long-term data from a prospective cohort of patients with nonalcoholic fatty liver disease, who reported their aspirin use regularly, provides evidence of hepatoprotective effects of daily aspirin.
Biography
Tracey Simon, MD, MPH, is a Hepatologist in the Division of Gastroenterology, and an Instructor of Medicine at Harvard Medical School. Dr. Simon treats all forms of liver disease, and specializes in the diagnosis and management of non-alcoholic fatty liver disease. Her research focuses on developing strategies to prevent cirrhosis, and reduce the risk for hepatocellular carcinoma.
Digestive Healthcare at Mass General
The Massachusetts General Hospital Digestive Healthcare Center is a collaborative practice of gastroenterologists, endoscopists, surgeons, radiologists, pathologists, hepatologists, oncologists and radiation oncologists dedicated to the prevention, diagnosis, treatment and management of digestive diseases.
